Advanced search
Start date
Betweenand


Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy

Full text
Author(s):
Schmidt, Dayane ; Ebrahimabadi, Sima ; de Sena Gomes, Kauan Ribeiro ; Aguiar, Graziela de Moura ; Tirapelle, Mariane Cariati ; Silvestre, Renata Nacasaki ; Cottas de Azevedo, Julia Teixeira ; Covas, Dimas Tadeu ; Picanco-Castro, Virginia
Total Authors: 9
Document type: Journal article
Source: IMMUNOTHERAPY ADVANCES; v. 2, n. 1, p. 14-pg., 2022-04-06.
Abstract

Cell therapy is an innovative approach that permits numerous possibilities in the field of cancer treatment. CAR-T cells have been successfully used in patients with hematologic relapsed/refractory. However, the need for autologous sources for T cells is still a major drawback. CAR-NK cells have emerged as a promising resource using allogeneic cells that could be established as an off-the-shelf treatment. NK cells can be obtained from various sources, such as peripheral blood (PB), bone marrow, umbilical cord blood (CB), and induced pluripotent stem cells (iPSC), as well as cell lines. Genetic engineering of NK cells to express different CAR constructs for hematological cancers and solid tumors has shown promising preclinical results and they are currently being explored in multiple clinical trials. Several strategies have been employed to improve CAR-NK-cell expansion and cytotoxicity efficiency. In this article, we review the latest achievements and progress made in the field of CAR-NK-cell therapy. (AU)

FAPESP's process: 13/08135-2 - CTC - Center for Cell-Based Therapy
Grantee:Dimas Tadeu Covas
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 19/25309-0 - Off-the-shelf engineered NK cells for the treatment of Leukemia and Lymphoma treatment
Grantee:Virginia Picanço e Castro
Support Opportunities: Regular Research Grants
FAPESP's process: 20/08279-8 - Establishment of a platform for generating NK-CAR cells with greater therapeutic effectiveness in vitro and in vivo
Grantee:Júlia Teixeira Cottas de Azevedo
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 20/09206-4 - Prospection of technological trends in immunotherapy in the area of gene therapy
Grantee:Kauan Ribeiro de Sena Gomes
Support Opportunities: Scholarships in Brazil - Doctorate